NCT04455295View on ClinicalTrials.gov

Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation

NAActive, not recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
no ConditionElectroencephalographyPupil Diameter
Interventions
DEVICE

Transdermal Vagus Nerve Stimulation (tVNS)

Mild non-invasive transdermal electrical stimulation at the ear (0.0-1.0 mA, 0.0-30.0 Hz). Used in previous studies with no unexpected adverse events. Stimulator not considered a FDA regulated device in previous studies.

Trial Locations (1)

72801

Arkansas Tech University, Russellville

All Listed Sponsors
lead

Arkansas Tech University

OTHER